Keith Maher, MD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith Maher, MD
Earlier roles on record: Board Member at Avalo Therapeutics, Inc. (AVTX) until August 8, 2022. Avalo Therapeutics, Inc. reported in an 8-K filed August 11, 2022 that Keith Maher, MD resigned as the Board, effective August 8, 2022.
“On August 8, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the "Master Fund"), notified the Board of Directors (the "Board") of Avalo Therapeutics, Inc. (the "Company") that they have resigned from their positions on the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-10-15–2022-08-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.